Nexalin seeks $10M in IPO for neuro devices to treat anxiety, insomnia (Pending:NXL)
Medical device developer Nexalin Technology (NXL) has filed to raise $10M in an IPO aimed at funding development of its neurostimulation devices to treat anxiety and insomnia.
Source: seekingalpha.com